|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Short-term investments | |||||
| Restricted cash, current | |||||
| Accounts receivable, net | |||||
| Advanced payments, current | |||||
| Contract assets | |||||
| Other current assets | |||||
| Total current assets | |||||
| Advanced payments, less current portion | |||||
| Property and equipment, net | |||||
| Restricted cash, less current portion | |||||
| Right-of-use assets - operating leases | |||||
| Right-of-use assets - finance leases | |||||
| Intangible assets, net | |||||
| Goodwill | |||||
| Other assets, less current portion | |||||
| Total assets | |||||
| Liabilities and stockholders' equity | |||||
| Current liabilities: | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accounts payable and accrued expenses - related parties | |||||
| Operating lease liability, current | |||||
| Finance lease liability, current | |||||
| Deferred revenue, current | |||||
| Notes payable, current | |||||
| Other current liabilities | |||||
| Total current liabilities | |||||
| Operating lease liability, less current portion | |||||
| Finance lease liability, less current portion | |||||
| Deferred revenue, less current portion | |||||
| Notes payable, less current portion | |||||
| Notes payable, less current portion - related parties | |||||
| Warrant liability | |||||
| Other liabilities, less current portion | |||||
| Total liabilities | |||||
| Temporary equity | |||||
| Redeemable convertible preferred stock, $0.0001 par value; 100,000 and 51,033 shares authorized as of December 31, 2025 and March 31, 2026, respectively; 0 and 41,588 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; $0 and $1,227,158 liquidation preference as of March 31, 2026 and December 31, 2025, respectively | |||||
| Stockholders' equity | |||||
| Common stock, $0.0001 par value, 1,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 166,207 and 159,276 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||
| Additional paid-in capital, net | |||||
| Accumulated deficit | |||||
| Total stockholders' equity | |||||
| Total liabilities and stockholders' equity |
Loading...